心力衰竭患者的液体限制与自由摄入:随机试验的元分析
Agata Bielecka-Dabrowa1,2, Maciej Banach1,2,3, Danisha Kumar4
1Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.
ESC heart failure
|February 19, 2026
概括
心力衰竭 (HF) 患者的液体限制显著降低了全因死亡风险. 然而,它没有显示出对HF再入院的显著影响,这表明需要进一步研究临床实践指南.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 由于证据不足,目前的指导方针对症状性心力衰竭 (HF) 的液体限制 (FR) 提出了有限的建议.
- 这项研究评估了FR对HF患者死亡率,再入院和生物标志物的影响.
研究的目的:
- 评估液体限制在降低心力衰竭患者全因死亡率和再入院的有效性.
- 研究液体限制对心力衰竭患者感知口渴,BNP和水平的影响.
主要方法:
- 在PubMed,Embase和Clinicaltrials.gov上进行了系统的文献搜索,搜索到2025年6月的随机对照试验 (RCT).
- 聚合分析利用随机效应模型与Hartung-Knapp-Sidik-Jonkman调整来确定风险比率和加权平均差异.
主要成果:
- 分析了9个涉及1271名患者的RCT. 限制饮用液体显著降低了因任何原因死亡的风险 (RR = 0.54;P = 0.03).
- 在心力衰竭再住院 (RR = 0.67;P = 0.31),感知口渴 (WMD = -6.89;P = 0.26),血清BNP水平 (WMD = 54.09 pg/mL;P = 0.71) 或水平 (WMD = 1.42 mmol/L;P = 0.15) 中没有发现显著差异.
结论:
- 心力衰竭患者的液体限制与全因死亡风险降低有关.
- 液体限制没有显著影响高压再入院,感知口渴或关键生物标志物,这表明需要进一步研究来完善临床实践指南.
相关概念视频
01:22Heart Failure Drugs: Diuretics
2.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
2.0K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
01:28Mitral Regurgitation IV: Nursing Management
608
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
608
01:30Heart Failure V: Medical Management
642
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642
01:22Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
01:30Heart Failure VII: Nursing Interventions
807
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
807